We found that O-Man core M2 glycosylation plays a role in maintaining cellular PTPRZ levels because GnT-IX knockdown reduced PTPRZ levels in glioma cells and led to significantly reduced tumor growth in a xenograft glioma model. The gene discussed is PTPRZ1; the disease is central nervous system cancer.